The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is projected to grow significantly, reaching USD 2.8 billion by 2032 from an estimated USD 1.5 billion in 2022. This growth is driven by rising cancer cases worldwide, according to industry forecasts.
A report by Future Market Insights (FMI) indicates that the ERCP devices market will expand at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2032. ERCP devices combine fluoroscopic imaging and endoscopy, facilitating the insertion of tools into the biliary and pancreatic ducts through the duodenal papilla.
Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9658
These devices play a crucial role in diagnosing and treating pancreaticobiliary disorders, utilizing side-view duodenoscopy introduced via the esophagus and stomach to the duodenum. They are instrumental in sampling cells and tissues and treating blockages in the bile or pancreatic duct.
With magnetic resonance cholangiopancreatography devices and computed tomography machines serving as alternatives, the demand for ERCP devices is expected to remain robust in the foreseeable future.
Key Takeaways: ERCP Device Market Growth
- The global market for ERCP devices is expected to reach USD 2.8 billion by 2032, up from USD 1.5 billion in 2022, driven by a rise in global cancer cases.
- North America leads the market due to strong healthcare infrastructure, research focus, and established players.
- Asia Pacific is expected to see the fastest growth due to government investments in healthcare and rising awareness of ERCP procedures. China and Japan hold a significant share in this region.
- Europe is also expected to grow due to increased healthcare spending and infrastructure improvements.
Key Market Participants:
Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Cook Medical, Inc., Hobbs Medical, Merit Medical Systems, and TeleMed Systems, Inc. are a few market participants identified across the value chain in the global endoscopic retrograde cholangiopancreatography (ECRP) devices market.
Get a Purchase on the Report: https://www.futuremarketinsights.com/checkout/9658
Key Segmentation:
By Disease Indication
- Gastroesophageal Reflux Disease
- GI Cancer
- Barrett’s Esophagus
- Bile Duct Diseases
- Peptic Ulcer Disease
- Crohn’s Disease
- Intestinal Pseudo-Obstruction and Ogilvie Syndrome
- Other Disease Indications
By Product Type:
- Sphincterotomes
- Lithotripter
- Endoscopes
- Accessories
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Others (Baskets etc.)
By End User:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
